Interaction of shiga toxin with the a-domains and multimers of von Willebrand Factor

Journal of Biological Chemistry

Volumn 288, Issue 46, 2013, Pages 33118-33123

  Lo, Nathan C ^a   Turner, Nancy A ^a   Cruz, Miguel A ^b,c   Moake, Joel ^a  

^a Rice University   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENTEROHEMORRHAGIC ESCHERICHIA COLI; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; PATHOPHYSIOLOGY; PEPTIDE BONDS; PLASMA GLYCOPROTEINS; PLATELET ADHESION; SHIGA TOXIN; VON WILLEBRAND FACTOR;

ESCHERICHIA COLI; GLYCOPROTEINS;

ENDOTHELIAL CELLS;

METHIONINE; SHIGA TOXIN; TYROSINE; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; CHEMICAL BOND; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MULTIMERIZATION; PROTEIN SECRETION; UMBILICAL VEIN ENDOTHELIAL CELL;

ADAMTS13; HEMOLYTIC UREMIA; PLATELETS; SHIGA TOXIN; THROMBOSIS; TOXINS; VON WILLEBRAND FACTOR;

ADAM PROTEINS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SHIGA TOXIN 1; VON WILLEBRAND FACTOR;

EID: 84887840553     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.487413     Document Type: Article

References (32)

1. Keir, L. S., Marks, S. D., and Kim, J. J. (2012) Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des. Devel. Ther. 6, 195-208
2. Garg, A. X., Suri, R. S., Barrowman, N., Rehman, F., Matsell, D., Rosas-Arellano, M. P., Salvadori, M., Haynes, R. B., and Clark, W. F. (2003) Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290, 1360-1370
3. Moake, J. L. (2002) Thrombotic microangiopathies. N. Engl. J. Med. 347, 589-600
4. Nolasco, L.H., Turner, N. A., Bernardo, A., Tao, Z., Cleary, T. G., Dong, J. F., and Moake, J. L. (2005) Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. Blood 106, 4199-4209
5. Cleary, T. G. (1988) Cytotoxin-producing Escherichia coli and the hemolytic uremic syndrome. Pediatr. Clin. North Am. 35, 485-501
6. Matussek, A., Lauber, J., Bergau, A., Hansen, W., Rohde, M., Dittmar, K. E., Gunzer, M., Mengel, M., Gatzlaff, P., Hartmann, M., Buer, J., and Gunzer, F. (2003) Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells. Blood 102, 1323-1332
7. Odumosu, O., Nicholas, D., Yano, H., and Langridge, W. (2010) AB toxins: a paradigm switch from deadly to desirable. Toxins 2, 1612-1645
8. He, X., Quiñones, B., McMahon, S., and Mandrell, R. E. (2012) A singlestep purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli. Toxins 4, 487-504
9. Huang, J., Motto, D. G., Bundle, D. R., and Sadler, J. E. (2010) Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice. Blood 116, 3653-3659
10. Tarr, P. I., Gordon, C. A., and Chandler, W. L. (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073-1086
11. Trachtman, H., Austin, C., Lewinski, M., and Stahl, R. A. (2012) Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat. Rev. Nephrol. 8, 658-669
12. Siegler, R. L., Pysher, T. J., Tesh, V. L., and Taylor, F. B., Jr. (2001) Response to single and divided doses of Shiga toxin-1 in a primate model of hemolytic uremic syndrome. J. Am. Soc. Nephrol. 12, 1458-1467
13. Courtecuisse, V., Habib, R., and Monnier, C. (1967) Nonlethal hemolytic and uremic syndromes in children: an electron-microscope study of renal biopsies from six cases. Exp. Mol. Pathol. 7, 327-347
14. Katz, J., Krawitz, S., Sacks, P. V., Levin, S. E., Thomson, P., Levin, J., and Metz, J. (1973) Platelet, erythrocyte, and fibrinogen kinetics in the hemolytic-uremic syndrome of infancy. J. Pediatr. 83, 739-748
15. Habib, R., Levy, M., Gagnadoux, M. F., and Broyer, M. (1982) Prognosis of the hemolytic uremic syndrome in children. in Advances in Nephrology (Hamburger, J., Crosnier, J., and Grunfeld, J.-P., eds) Vol. 2, pp. 99-128, Yearbook Medical, Chicago
16. Pysher, T. J., Siegler, R. L., Tesh, V. L., and Taylor, F. B., Jr. (2002) von Willebrand Factor expression in a Shiga toxin-mediated primate model of hemolytic uremic syndrome. Pediatr. Dev. Pathol. 5, 472-479
17. Tsai, M., Kita, A., Leach, J., Rounsevell, R., Huang, J. N., Moake, J., Ware, R. E., Fletcher, D. A., and Lam, W. A. (2012) In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J. Clin. Invest. 122, 408-418
18. Hughes, A. K., Stricklett, P. K., and Kohan, D. E. (2001) Shiga toxin-1 regulation of cytokine production by human glomerular epithelial cells. Nephron 88, 14-23
19. Studt, J. D., Kremer Hovinga, J. A., Alberio, L., Bianchi, V., and Lämmle, B. (2003) Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory. Swiss Med. Wkly 133, 325-332
20. Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P. A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M., and Lämmle, B. (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N. Engl. J. Med. 339, 1578-1584
21. Tsai, H. M., Chandler, W. L., Sarode, R., Hoffman, R., Jelacic, S., Habeeb, R. L., Watkins, S. L., Wong, C. S., Williams, G. D., and Tarr, P. I. (2001) von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr. Res. 49, 653-659
22. Auton, M., Sowa, K. E., Smith, S. M., Sedlák, E., Vijayan, K. V., and Cruz, M. A. (2010) Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibα and platelet activation under shear stress. J. Biol. Chem. 285, 22831-22839
23. Martin, C., Morales, L. D., and Cruz, M. A. (2007) Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibß. J. Thromb. Haemost. 5, 1363-1370
24. Auton, M., Cruz, M. A., and Moake, J. (2007) Conformational stability and domain unfolding of the Von Willebrand factor A domains. J. Mol. Biol. 366, 986-1000
25. Cruz, M. A., Yuan, H., Lee, J. R., Wise, R. J., and Handin, R. I. (1995) Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides. J. Biol. Chem. 270, 10822-10827
26. Cruz, M. A., Handin, R. I., and Wise, R. J. (1993) The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein. J. Biol. Chem. 268, 21238-21245
27. Kokame, K., Nobe, Y., Kokubo, Y., Okayama, A., and Miyata, T. (2005) FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br. J. Haematol. 129, 93-100
28. Veyradier, A., Obert, B., Houllier, A., Meyer, D., and Girma, J. P. (2001) Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 98, 1765-1772
29. Morales, L. D., Martin, C., and Cruz, M. A. (2006) The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen. J. Thromb. Haemost. 4, 417-425
30. Inbal, A., and Loscalzo, J. (1989) Glycocalicin binding to von Willebrand factor adsorbed onto collagen-coated or polystyrene surfaces. Thromb. Res. 56, 347-357
31. Liu, F., Huang, J., and Sadler, J. E. (2011) Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways. Blood 118, 3392-3398
32. Foster, G. H., and Tesh, V. L. (2002) Shiga toxin 1-induced activation of c-Jun NH2-terminal kinase and p38 in the human monocytic cell line THP-1: possible involvement in the production of TNF-α. J. Leukoc. Biol. 71, 107-114